Combinatorial Analysis of AT-Rich Interaction Domain 1A and CD47 in Gastric Cancer Patients Reveals Markers of Prognosis
Background: The AT-rich interaction domain 1A (ARID1A) is thought to be a tumor suppressive gene, and most of its mutations result in loss of expression of ARID1A protein. Combined with SIRPα on the surface of macrophages, CD47 on the surface of cancer cells can send an antiphagocytic “Don’t eat me”...
Main Authors: | Qianfu Zhao, Qu Cai, Shanhe Yu, Jun Ji, Zhenggang Zhu, Chao Yan, Jun Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-11-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2021.745120/full |
Similar Items
-
Expression of CRT and CD47 in Gastric Carcinoma and Their Significance
by: SUN Ke, et al.
Published: (2019-01-01) -
Opportunities and challenges for anti-CD47 antibodies in hematological malignancies
by: Yilan Xu, et al.
Published: (2024-02-01) -
A Novel Blockade CD47 Antibody With Therapeutic Potential for Cancer
by: Fangzhen Lin, et al.
Published: (2021-01-01) -
Structural–functional diversity of CD47 proteoforms
by: Ting Zhang, et al.
Published: (2024-02-01) -
TIGIT/CD47 dual high expression predicts prognosis and is associated with immunotherapy response in lung squamous cell carcinoma
by: Yue Peng, et al.
Published: (2022-07-01)